Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) was upgraded by equities researchers at StockNews.com to a “sell” rating in a research report issued on Friday. Other equities research analysts ...

The S&P 500 rose 9.5 percent after President Trump announced he would pause his “reciprocal” tariffs for 90 days, but ...

Continue reading Editorial Note: We earn a commission ... activity in Washington, D.C., amid job eliminations and return-to-office mandates. With record-high home prices still trending upward ...

The N.C. State women’s basketball team took a while to get warmed up Saturday, but the second-seeded Wolfpack pulled away in the second half to clip upset-minded No. 15 Vermont.

The following is an update to the first quarter 2025 outlook and gives an overview of our current expectations for the first quarter. Outlooks presented may vary from the actual first quarter 2025 ...

The following is an update to the first quarter 2025 outlook and gives an overview of our current expectations for the first quarter. Outlooks presented may vary from the actual first quarter ...

Seniors: Deena Alasaad, Jayson Allard, Amal Bushnaq, Vincent Chen, Lauren Chenevert, Madison Cunha, Mackenzie Doyle, Madison Doyle, Jack Feeney, Hamzah Gargaja ...

After hammering out a 17.4% average gain for all of 2024, the average U.S.-stock mutual fund or exchange-traded fund fell 5.1% in the first quarter, according to LSEG. Concerns about tariffs and ...

A high-ranking city official in Oakland, California, has been fired over a resurfaced note that showed her referring to black people as “tokens,” according to reports. Chief of staff Leigh ...

H.C. Wainwright analyst Patrick Trucchio initiated coverage of Alto Neuroscience (ANRO) with a Buy rating and $10 price target Alto is ...